Skip to main content
North American Journal of Medical Sciences logoLink to North American Journal of Medical Sciences
. 2009 Oct;1(5):220–225.

Computer diagnosis in cardiology: oxidative stress hypothesis

Ezekiel Uba Nwose 1,, Graham Wilfred Ewing 2
PMCID: PMC3364613  PMID: 22666699

Abstract

Background:

Virtual scanning is one of the emerging technologies in complementary medicine practice. The diagnostic principle is hinged on perception and ultra weak light emission, while the treatment options associated with it includes diet, flash light, exercise and relaxation. However, a mechanism that links the diagnostic and treatment principles has yet to be elucidated.

Aims:

The objective here is to further explanation of oxidative stress concept as the biochemical basis of the technology.

Materials and Methods:

Using available literature and basic science textbook, the function of the hypothalamus-pituitary-adrenalin axis as neuro-endocrine physiological system that is strongly linked to the rate of alterations in biochemical processes through to cardiovascular complications is articulated.

Results:

The hypothesis brings to fore the potential of using the alterations in biochemical processes associated with cognition as tool to validate the Virtual Scanning technology for possible incorporation into clinical practice. Or vice versa to use Virtual Scanning technology to determine the chemiluminescence-related biochemical changes resulting from pathologies that could benefit from relaxation, light therapy, exercise and antioxidant nutrition.

Conclusions:

This article advances the applicability of cognitive test procedure for indication of the disease(s) affecting heart function. The implication for some laboratory indices that are already available in clinical practice is highlighted. Investigation of this hypothesis will help provide clear link between plausible mechanism and the theory proposed.

Keywords: Virtual scanning, oxidative stress indices, chemiluminescence, clinical diagnosis, computer technology, cardiology

Introduction

Advances in noninvasive technologies in cardiology are growing and improving both the diagnosis of heart disease and the guidance of therapy[1]. There are currently many emerging technologies, which are being used in the alternative and complementary medicine practice, including computer meridian diagnostics and Virtual scanning. The latter has been presented earlier in this volume[2].

Suffice to note that the body is a dynamic system in which reaction kinetics are affected by the reaction conditions. This influences the levels of biochemicals and the rates at which they react.

Many commonly observed visual perception deficits are associated with disease states and altered biochemistry. In particular, visual defects are associated with heart condition[35]. Associated with the defects are antioxidant activities[68], which in turn are associated to adenosine triphosphate (ATP) metabolism[9]. Changes to the levels of proteins and reactive substrates in the body cause the release of ultra weak light or chemiluminescence[10]. Examples of substrates and/or products of reactions that involve chemiluminescence include antioxidants and ATP respectively[11,12].

Biochemistry of brain-heart connection: biochemical alterations during stress

Oxidative stress is biochemical basis of biological ‘stress’

Generally, stress in health is physiological or psychosocial. The concept of stress is related to the complexity of the interactions between the cells, organs and systems of the body. The body wishes ‘constancy of the internal environment’ (homeostasis). This was first described by a 19th century physiologist, Claude Bernard[13]. The constancy, homeostasis or steady-state condition means that any tendency towards change is either automatically resisted by a feedback or feedforward response. Failure of the response to restore homeostasis results in pathology and chronic illness[1416].

Two of the adrenal hormones involved in the neuro-endocrine response to stress are catecholamines and glucocorticoids. The latter mainly potentiates the former. The catecholamines decrease insulin production and increase glucagon's release, which culminate in increased glucose level in the blood vis-à-vis glucose metabolism[13].

Normal human physiological processes are strongly dependent on glucose metabolism (i.e. the biochemical process) for the generation of energy. Glucose metabolism is a cell level (glycolysis and hexose monophosphate shunt pathways) activity that inherently generates free radicals (oxidants). When a free radical reacts with a molecule, a new radical is always formed. The new radical readily reacts with another molecule to produce yet another radical, and this continues exponentially until the radicals react with a chain breaking molecule (antioxidant), which will result in the formation of a stable product. Typical examples of antioxidants are vitamins C and E. Others are glutathione, coenzyme-Q10 and carotenoid. They are abundant in the human body.

There is a paradox that many antioxidants including vitamins C and E are potentially toxic. Recalling the famous chemistry slogan atoms can neither be created nor destroyed, an antioxidant vitamin that has finished a much needed reaction is not destroyed. It is transformed into a reaction product or intermediate, which has pro-oxidant toxic potentials and therefore requires recycling back to its original state. In good health, there are co-antioxidants in a delicately balanced or closed circuit interaction (Fig. 1).

Fig 1.

Fig 1

Closed-circuit nature of co-antioxidants interaction network - Vitamin E regeneration system[17]. “Keys: AA = ascorbic acid, CoQ = oxidized coenzyme-Q10, CoQ-H2 = coenzyme-Q10, CVD = cardiovascular disease, DHA = dehydro-ascorbic acid (free radical), GR = glutathione reductase, GSH = reduced glutathione, GSSG = oxidized glutathione, LOO▪ = lipid peroxyl radical, LOOH = lipid peroxide, OS = oxidative stress, RC = mitochondrial respiratory chain, TOH = tocopherol (vitamin e), TO▪ = tocopheroxyl radical”.

Brain and heart connection

A major part of neuroendocrine system involved in stress adaptation is the hypothalamus-pituitary-adrenalin axis (HPAA). When there is stress, there is release of adrenal hormones and associated with this is increased glucose metabolism. If the stress condition is prolonged (chronic), there will also be chronic increase in glucose metabolism (similar to an undiagnosed diabetic state). This leads to more-than-normal-level production of free radicals – and by default, an alteration in the body's biochemical makeup.

Among the obvious alterations in biochemical makeup are increased ATP generation and reduction in cellular antioxidant levels. The latter exacerbates oxidative stress and is a factor in cardiological complications. Specifically, when oxidative stress involves the red blood cells[18], the biochemical alterations drive the physiology as in the flow diagram (Fig 2). The figure illustrates how stress (such as chronic anxiety) can cause hypertension and increased heart rate en route cardiological diseases.

Fig. 2.

Fig. 2

Sequence of how stress can cause cardiovascular complications[19]. “Keys: 1=GSH supplementation; 2=vitamin E and other co-antioxidant supplementation”

Implication for colour perception

It is known that antioxidant activities involve reactions with proteins with concomitant emission of ultra weak light and are increased in obstructive sleep apnoea states[20]. It is also known that oxidants contribute to the exacerbation of sleep apnoea, particularly including the cardiovascular complications[21]. At this juncture, it is pertinent to note at least the following half-a-dozen points:

  1. Biochemical changes associated with disease or drug substances influence perception of color[3].

  2. Changes to the levels of proteins and reactive substrates in the body cause the release of ultra-weak light albeit chemiluminescence[10].

  3. The emissions are measurable luminescence as index of oxidative stress[22].

  4. Oxidative stress as a common event that can lead to emission of chemiluminescence has been indicated in studies on erythrocytes[23]. Further support is provided by studies indicating that emission can be attenuated or increased by addition of antioxidants or reactive oxygen species respectively[2426].

  5. ATP is the ultimate of glucose metabolism. The associated increase in free radicals is involved in chemiluminescence when a high energy state intermediate changes to a lower energy state. Above all, alteration in ATP level is correlated to photon chemiluminescence[27].

  6. Photon emission affects color or heat perception and intensity and this property is utilized in CT scan[28]. Therefore, abnormal level of emissions arising from biochemical processes during disease conditions could affect color vision.

What this article brings to fore is that there is a non-invasive cognitive test procedure, Virtual Scanning technology, which utilizes the chemiluminescence arising from biochemical processes to assess and manage stress-related cardiological conditions. The biochemical basis of the technology has not been previously explained, except as implied in our papers[2932]. This article furthers explanation that oxidative stress effect of luminescence on cognition and colour perception is possibly the biochemical basis of Virtual Scanning technology.

The Virtual Scanning

Principle

It may be likened to other emission-based technologies such as CT scan, magnetic resonance, or ultrasound, but there is a difference. Other technologies involve the body's interaction with, and response to, some exogenous agents being inputted to the system as source of emission. Virtual Scanning is based upon the body's inherent biochemical processes as source of light emission and defects in color perception.

The cognitive test procedure, which is presented earlier in this volume[2], is based upon restoring the colors of an image on a computer. The computer then processes the patient's response and shows the results on the screen. Each condition comprises a pair of blue and red signals. The red signals report the extent of the pathology whilst the blue signal reports the extent of the body's natural compensatory response (Fig. 3). In general, signals below 10-units are pre-symptomatic whilst those above 10-units are symptomatic.

Fig. 3.

Fig. 3

A typical Virtual Scanning report indicating cardiological problem[2]. “Formatted comments included in the report Compensatory signal: 5/0 Ischemic Heart Disease Expressed pathological signals (from left to right): 15/31 Angina Pectoris, 7/17 Cardiosclerosis, 7/17 Chronic Fatigue, 3/31 Cardiac Insufficiency, 0/24 Cardiac myopathy”

Therapeutic

The diagnosis procedure ends with a recommendation of patient treatment strategy and the standard therapy involve a basic concept of three stages[33]. First, the area (organ, system) where correction is necessary and features that are subject to correction are identified. Second, the course or dose and sessions of flashing light therapy are determined.

The Virtual Scanning light therapy involves the presentation of flash lights of uniquely selected colors, shapes and frequencies. The emission is transmitted at delta frequencies to the autonomic nervous system by the computer through his eyes. The third stage of the therapeutic procedure is where healing signals are sensed, as the patient's system (vision) responds, through the monitor. The brain establishes synchronized neural function – and hence synchronized function of the autonomic nervous system and physiological systems – thereby restoring its normal physiological stability and functions[33]. The principle is referred variously as brain-wave coherence, brain-wave entrainment, or photic stimulation amongst others[34,35]. One session of treatment takes average of 30 minutes and one module of therapy comprises typically 24-36 sessions. Several modules of therapy may be required. Other treatment options of Virtual Scanning technology (not emphasized in this article) are nutrition, exercise and relaxation.

Applicability to cardiology: Does light therapy attenuate cardiology problems?

We have explained that metabolic and physiological interactions such as glucose metabolism and HPAA, respectively, enable the generation of reactive oxygen species and consequential existence of oxidative stress. The feedback and feedforward responses to oxidative stress reactions form the biochemical basis of pathological processes and systemic instability including cardiological problems (Fig. 2). The chemiluminescence arising from oxidative stress are perceived and memorized as characteristic of different disease conditions according to colour perception and intensity and attenuated by flash light using Virtual Scanning technology. Perhaps, the question would be ‘is this applicable to cardiological diseases?’

Light is conducted within the body along the acupuncture meridians, and clinical benefits of light therapy have been known[36]. What is yet unknown are the biochemical and/or metabolic basis of the light that is conducted within the body and the basis of therapeutic applicability in cardiology. We had posited that the biochemical basis of signal employed by Virtual Scanning technology is antioxidant activities. We postulate that oxidative stress induced chemiluminescence and susceptibility to flash light therapy is the basis of Virtual Scanning technology[29,30]. Furthermore, we rationalize the applicability to cardiological problems to be based on the attenuating effect of light on oxidative stress. Our postulation is based on the available itemized knowledge on flash light therapy in relation to cardiological problems:

  1. The level of blood glucose is a factor in Virtual Scanning technology[33]. Increased glucose metabolism is implicated in stress and cardiology (Fig. 2).

  2. Light therapy affects cortisol rhythm[37,38].

  3. Low level (infrared) light therapy attenuates hyperglycaemia-induced oxidative stress and enhances the antioxidant protection system[39].

  4. Flash light therapy attenuates venous cannulation pain[40].

  5. The concept of selective photothermolysis is applicable in vascular lesions management[41].

  6. Atherothrombosis can be cleared, at least in part, by flash light therapy by the principle of laser thrombolysis[42].

Therefore, given the available knowledge listed above, there is credible evidence that flash light therapy is applicable in the management of cardiological problems. However, validation research would be required to enable incorporation of any new technology such as Virtual Scanning into conventional clinical practice.

Suggestions of laboratory indices for validation research

A number of laboratory tools can be employed in a validation research. Salivary cortisol is a laboratory index in mental health and stress[38]. This is being incorporated in another closely-related emerging technology, Neuropattern, which is based on the argument on neurobehavioral medicine and stress-related disorders that manipulation of the brain by photostimulation technologies can be applied in clinical management[43]. While Neuropattern technology acknowledges cortisol rhythm without recourse to light therapy, Virtual Scanning uses light therapy without recourse to laboratory assessment of cortisol. Therefore, except for reason of availability and cost effectiveness, salivary cortisol test can be employed to monitor and validate therapeutic outcome in Virtual Scanning.

Based on Fig. 2, a panel of tests can be developed from currently available laboratory indices. This would include blood glucose level as well as vitamin C, vitamin E and whole blood viscosity. It would be expected that increased blood glucose level, antioxidant imbalance and increased whole blood viscosity will be observed at baseline stress; and normalized after Virtual Scanning therapy. This hypothesis is in agreement with the implication of oxidative stress and blood flow/shear stress that are involved in several processes of atherogenesis[44].

Conclusions

The association between the triage of (i) biological stress, (ii) cardiology, and (iii) cortisol level is known[45]. This paper articulates that color perception (i) is influenced by biological stress, (ii) is useful for the management of cardiological problems and (iii) can be monitored and validated using cortisol level or the suggested panel of associated biochemical indices, which are centered on oxidative stress. Especially, it is known that oxidative stress is a common mediator of apoptosis and cardiac damage and that antioxidant as adjuvant therapy is effective in improving parameters of cardiac function[46]. What this article contributes is a basis to use blood glucose level, vitamin C, vitamin E and whole blood viscosity as a laboratory panel to validate the technology for possible incorporation, as well as monitor the technology's treatment outcome in clinical practice. It has been argued that Virtual scanning technology lacks clear link between plausible mechanism and the theory proposed. It is hoped that investigation of this hypothesis will provide the missing link.

Acknowledgement

Graham Ewing & Elena Ewing (Dr) are Directors of Montague Healthcare, a company dedicated to the future commercialisation of Virtual Scanning. Dr. Ezekiel Nwose is currently doing a book. It is hoped that permission shall be requested for part of this article to be reproduced.

References

  • 1.Cuocolo A, Acampa W, Imbriaco M, De Luca N, Iovino GL, Salvatore M. The many ways to myocardial perfusion imaging. Q J Nucl Med Mol Imaging. 2005;49:4–18. [PubMed] [Google Scholar]
  • 2.Ewing GW, Ewing EN. Computer diagnosis in cardiology. North Am J Med Sci. 2009;1:152–159. [PMC free article] [PubMed] [Google Scholar]
  • 3.Rietbrock N, Alken RG. Color vision deficiencies: a common sign of intoxication in chronically digoxin-treated patients. J Cardiovasc Pharmacol. 1980;2:93–99. [PubMed] [Google Scholar]
  • 4.Rowe F VIS Group UK. Visual perceptual consequences of stroke. Strabismus. 2009;17:24–28. doi: 10.1080/09273970802678537. [DOI] [PubMed] [Google Scholar]
  • 5.Lee BH, Kim EJ, Ku BD, Choi KM, Seo SW, Kim GM, Chung CS, Heilman KM, Na DL. Cognitive impairments in patients with hemispatial neglect from acute right hemisphere stroke. Cogn Behav Neurol. 2008;21:73–76. doi: 10.1097/WNN.0b013e3181772101. [DOI] [PubMed] [Google Scholar]
  • 6.Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs. 2001;12:475–483. doi: 10.1097/00001813-200106000-00009. [DOI] [PubMed] [Google Scholar]
  • 7.De K, Roy K, Saha A, Sengupta C. Evaluation of alpha-tocopherol, probucol and ascorbic acid as suppressors of digoxin induced lipid peroxidation. Acta Pol Pharm. 2001;58:391–400. [PubMed] [Google Scholar]
  • 8.De K, Roy K, Saha A, Sengupta C. Exploring effects of different antioxidants on dexamethasone-induced lipid peroxidation using common laboratory markers. Acta Pol Pharm. 2004;61:77–86. [PubMed] [Google Scholar]
  • 9.Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication. Br J Biomed Sci. 2007;64:35–43. doi: 10.1080/09674845.2007.11732754. [DOI] [PubMed] [Google Scholar]
  • 10.Popp FA. Principles of complementary medicine in terms of a suggested scientific basis. Indian J Exp Biol. 2008;46:378–383. [PubMed] [Google Scholar]
  • 11.Curtin GM, Hanausek M, Walaszek Z, Mosberg AT, Slaga TJ. Short-term in vitro and in vivo analyses for assessing the tumor-promoting potentials of cigarette smoke condensates. Toxicol Sci. 2004;81:14–25. doi: 10.1093/toxsci/kfh172. [DOI] [PubMed] [Google Scholar]
  • 12.Dubuisson M, Marchand C, Rees JF. Firefly luciferin as antioxidant and light emitter: the evolution of insect bioluminescence. Luminescence. 2004;19:339–344. doi: 10.1002/bio.789. [DOI] [PubMed] [Google Scholar]
  • 13.Porth CM. Essentials of Pathophysiology – Concepts of Altered Health States. Lippincott Williams & Wilkins Sydney; 2007. pp. 151–164. [Google Scholar]
  • 14.Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29:567–592. doi: 10.1016/S0306-4530(03)00091-X. [DOI] [PubMed] [Google Scholar]
  • 15.Ursin H, Eriksen H. Cognitive activation theory of stress, sensitization, and common health complaints. Ann N Y Acad Sci. 2007;1113:304–310. doi: 10.1196/annals.1391.024. [DOI] [PubMed] [Google Scholar]
  • 16.Logan JG, Barksdale DJ. Allostasis and allostatic load: expanding the discourse on stress and cardiovascular disease. J Clin Nurs. 2008;17:201–208. doi: 10.1111/j.1365-2702.2008.02347.x. [DOI] [PubMed] [Google Scholar]
  • 17.Nwose EU, Jelinek HF, Richards RS, Kerr PG. The ‘vitamin E regeneration system’ (VERS) and an algorithm to justify antioxidant supplementation in diabetes - a hypothesis. Med Hypotheses. 2008;70:1002–1008. doi: 10.1016/j.mehy.2007.07.048. [DOI] [PubMed] [Google Scholar]
  • 18.Muda P, Kampus P, Zilmer M, Zilmer K, Kairane C, Ristimäe T, Fischer K, Teesalu R. Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients. J Hypertens. 2003;21:2329–2333. doi: 10.1097/00004872-200312000-00022. [DOI] [PubMed] [Google Scholar]
  • 19.Nwose EU, Jelinek HF, Richards RS, Kerr PG. 2008. Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications. Br J Biomed Sci. 2008;65:136–141. doi: 10.1080/09674845.2008.11732817. [DOI] [PubMed] [Google Scholar]
  • 20.Dikmenoğlu N, Ciftçi B, Ileri E, Güven SF, Seringeç N, Aksoy Y, Ercil D. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med. 2006;7:255–261. doi: 10.1016/j.sleep.2005.12.005. [DOI] [PubMed] [Google Scholar]
  • 21.Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology. 2005;104:92–96. doi: 10.1159/000086729. [DOI] [PubMed] [Google Scholar]
  • 22.Rummel’ NN, Kratasyuk VA, Maznyak OM, Inzhevatkin EV, Nefedov VP. Bioluminescent analysis of intensity of pathological oxidative processes in cells of perfused rat liver after hyperthermia. Bull Exp Biol Med. 2003;135:43–45. doi: 10.1023/a:1023489727703. [DOI] [PubMed] [Google Scholar]
  • 23.Casado MF, Cecchini AL, Simão AN, Oliveira RD, Cecchini R. Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol. 2007;45:945–952. doi: 10.1016/j.fct.2006.12.001. [DOI] [PubMed] [Google Scholar]
  • 24.Boveris A, Cadenas E, Reiter R, Filipkowski M, Nakase Y, Chance B. Organ chemiluminescence: noninvasive assay for oxidative radical reactions. Proc Natl Acad Sci USA. 1980;77:347–351. doi: 10.1073/pnas.77.1.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ursini F, Barsacchi R, Pelosi G, Benassi A. Oxidative stress in the rat heart, studies on low-level chemiluminescence. J Biolumin Chemilumin. 1989;4:241–244. doi: 10.1002/bio.1170040134. [DOI] [PubMed] [Google Scholar]
  • 26.Barsacchi R, Coassin M, Maiorino M, Pelosi G, Simonelli C, Ursini F. Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: protective role of vitamin E. Free Radic Biol Med. 1989;6:573–579. doi: 10.1016/0891-5849(89)90063-4. [DOI] [PubMed] [Google Scholar]
  • 27.Lagido C, McLaggan D, Flett A, Pettitt J, Glover LA. Rapid sublethal toxicity assessment using bioluminescent Caenorhabditis elegans, a novel whole-animal metabolic biosensor. Toxicol Sci. 2009;109:88–95. doi: 10.1093/toxsci/kfp058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mimura M, Watanabe R, Kato M, Kashima H. Selective memory impairment for personally familiar colors following encephalitis. Psychiatry Clin Neurosci. 2005;59:215–218. doi: 10.1111/j.1440-1819.2005.01361.x. [DOI] [PubMed] [Google Scholar]
  • 29.Nwose EU, Ewing G, Ewing E. Migraine can be managed with Virtual Scanning: case report. The Open Complementary Medicine Journal. 2009;1:16–18. [Google Scholar]
  • 30.Ewing GW, Ewing EN, Nwose EU. Virtual Scanning technology – the relationship to oxidative stress and applicability to diabetes management. Biogenic Amines. 2008;22:195–207. [Google Scholar]
  • 31.Hankey A, Ewing E.N. New light on chromotherapy: Grakov's ‘Virtual Scanning’ system of medical assessment and treatment. Evid Based Complement Alternat Med. 2007;4:139–144. doi: 10.1093/ecam/nel060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ewing G, Ewing E, Hankey A. Virtual scanning--a new system of medical assessment and treatment: Part I. Assessment. J Altern Complement Med. 2007;13:271–285. doi: 10.1089/acm.2006.5207. [DOI] [PubMed] [Google Scholar]
  • 33.Ewing GW, Ewing EN. Cognition, the Autonomic Nervous System and the Physiological Systems. Biogenic Amines. 2008;22:140–162. [Google Scholar]
  • 34.Will U, Berg E. Brain wave synchronization and entrainment to periodic acoustic stimuli. Neurosci Lett. 2007;424:55–60. doi: 10.1016/j.neulet.2007.07.036. [DOI] [PubMed] [Google Scholar]
  • 35.Noton D. Migraine and photic stimulation: report on a survey of migraineurs using flickering light therapy. Complement Ther Nurs Midwifery. 2000;6:138–142. doi: 10.1054/ctnm.2000.0477. [DOI] [PubMed] [Google Scholar]
  • 36.Cocilovo A. Colored light therapy: overview of its history, theory, recent developments and clinical applications combined with acupuncture. Am J Acupunct. 1999;27:71–83. [PubMed] [Google Scholar]
  • 37.James FO, Walker CD, Boivin DB. Controlled exposure to light and darkness realigns the salivary cortisol rhythm in night shift workers. Chronobiol Int. 2004;21:961–972. doi: 10.1081/cbi-200035944. [DOI] [PubMed] [Google Scholar]
  • 38.Lewis JG. Steroid Analysis in Saliva: An overview. Clin Biochem Rev. 2006;27:139–146. [PMC free article] [PubMed] [Google Scholar]
  • 39.Lim J, Ali ZM, Sanders RA, Snyder AC, Eells JT, Henshel DS, Watkins JB., JB Effects of low-level light therapy on hepatic antioxidant defense in acute and chronic diabetic rats. J Biochem Mol Toxicol. 2009;23:1–8. doi: 10.1002/jbt.20257. [DOI] [PubMed] [Google Scholar]
  • 40.Agarwal A, Yadav G, Gupta D, Tandon M, Singh PK, Singh U. The role of a flash of light for attenuation of venous cannulation pain: a prospective, randomized, placebo-controlled study. Anesth Analg. 2008;106:814–816. doi: 10.1213/ane.0b013e318163fcc6. [DOI] [PubMed] [Google Scholar]
  • 41.Dover JS. New approaches to the laser treatment of vascular lesions. Australas J Dermatol. 2000;41:14–18. doi: 10.1046/j.1440-0960.2000.00382.x. [DOI] [PubMed] [Google Scholar]
  • 42.Shangguan HQ, Gregory KW, Casperson LW, Prahl SA. Enhanced laser thrombolysis with photomechanical drug delivery: an in vitro study. Lasers Surg Med. 1998;23:151–160. doi: 10.1002/(sici)1096-9101(1998)23:3<151::aid-lsm4>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  • 43.Hellhammer DH, Hellhammer J, editors. Key Issues in Mental Health. Vol. 174. Basel: Karger; 2008. Stress. The Brain-Body Connection; pp. 1–20. [Google Scholar]
  • 44.Cibele MP, Marcos AR. Aorta Remodeling Responses to Distinct Atherogenic Stimuli: Hypertension, Hypercholesterolemia and Turbulent Flow/Low Wall Shear Stress. Open Cardiovasc Med J. 2008;2:41–48. doi: 10.2174/1874192400802010041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kario K, James GD, Marion R, Ahmed M, Pickering TG. The influence of work- and home-related stress on the levels and diurnal variation of ambulatory blood pressure and neurohumoral factors in employed women. Hypertens Res. 2002;25:499–506. doi: 10.1291/hypres.25.499. [DOI] [PubMed] [Google Scholar]
  • 46.Mohammad MD, Dimitri PM, Mohamed AH, Ismaeel MBJ, Olaa MT, Moshira AR, Hanaa ZY, Zeinb AAR, Ibrahim MI, Samy ME, Laila AR, Noha AA. Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats. Open Cardiovasc Med J. 2008;2:70–78. doi: 10.2174/1874192400802010070. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from North American Journal of Medical Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES